A large analysis of health records from 87 health care centers across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), particularly fluoxetine, were significantly less likely to die of COVID-19 than a matched control group.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/11/211115123538.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/11/211115123538.htm
COVID patients on SSRI antidepressants are less likely to die, study finds
![COVID patients on SSRI antidepressants are less likely to die, study finds]()
Reviewed by cmakigo
on
November 16, 2021
Rating:
No comments:
Post a Comment